top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Neurology image-based clinical review / / Jonathan Howard, Anuradha Singh
Neurology image-based clinical review / / Jonathan Howard, Anuradha Singh
Autore Howard Jonathan <1975->
Pubbl/distr/stampa New York, [New York] : , : Demos Medical Publishing, , 2017
Descrizione fisica 1 online resource (578 pages) : illustrations (some color)
Disciplina 616.80475
Soggetto topico Nervous system - Diseases - Diagnosis
Nervous system - Diseases - Treatment
Diagnostic Techniques, Neurological
Nervous System Diseases - therapy
Neuroimaging
Neurologic Examination
Diagnosis, Differential
Soggetto genere / forma Case Reports.
Electronic books.
ISBN 1-61705-280-9
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910527504503321
Howard Jonathan <1975->  
New York, [New York] : , : Demos Medical Publishing, , 2017
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Neuroprotection
Neuroprotection
Pubbl/distr/stampa [Chichester] : , : John Wiley & Sons, Ltd. on behalf of Chinese Medical Association, , 2023-
Disciplina 573.8
Soggetto topico Nervous system - Diseases - Treatment
Nervous system - Degeneration
Neuroprotective agents
Neurosciences
Soggetto genere / forma Periodicals.
Formato Materiale a stampa
Livello bibliografico Periodico
Lingua di pubblicazione eng
Record Nr. UNINA-9910805688603321
[Chichester] : , : John Wiley & Sons, Ltd. on behalf of Chinese Medical Association, , 2023-
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Neuroprotection
Neuroprotection
Pubbl/distr/stampa [Chichester] : , : John Wiley & Sons, Ltd. on behalf of Chinese Medical Association, , 2023-
Disciplina 573.8
Soggetto topico Nervous system - Diseases - Treatment
Nervous system - Degeneration
Neuroprotective agents
Neurosciences
Soggetto genere / forma Periodicals.
ISSN 2770-730X
Formato Materiale a stampa
Livello bibliografico Periodico
Lingua di pubblicazione eng
Record Nr. UNINA-9910708700303321
[Chichester] : , : John Wiley & Sons, Ltd. on behalf of Chinese Medical Association, , 2023-
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Neuroprotection / / edited by Matilde Otero-Losada, Capani, Francisco and Santiago Perez Lloret
Neuroprotection / / edited by Matilde Otero-Losada, Capani, Francisco and Santiago Perez Lloret
Pubbl/distr/stampa London, United Kingdom : , : IntechOpen, , 2020
Descrizione fisica 1 online resource (348 pages) : illustrations
Disciplina 616.8046
Soggetto topico Neuroprotective agents
Nervous system - Diseases - Treatment
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Altri titoli varianti Neuroprotection
Record Nr. UNINA-9910688294103321
London, United Kingdom : , : IntechOpen, , 2020
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Neuroprotection [[electronic resource] ] : models, mechanisms and therapies / / edited by Mathias Bähr
Neuroprotection [[electronic resource] ] : models, mechanisms and therapies / / edited by Mathias Bähr
Pubbl/distr/stampa Weinheim, : Wiley-VCH, c2004
Descrizione fisica 1 online resource (391 p.)
Disciplina 616.806
Altri autori (Persone) BährMathias
Soggetto topico Nervous system - Diseases - Treatment
Molecular neurobiology
Soggetto genere / forma Electronic books.
ISBN 1-280-51966-5
9786610519668
3-527-60386-7
3-527-60431-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Neuroprotection Models, Mechanismsand Therapies; Preface; Contents; List of Contributors; I Neurological Disorders - Epidemiology, Clinical Overview, and Model Systems; 1 Stroke; Abstract; 1.1 Introduction; 1.2 The Penumbra Concept; 1.3 Excitotoxicity; 1.4 Oxygen Free Radicals; 1.5 Tissue Acidosis; 1.6 Peri-infarct Depolarizations; 1.7 Inflammation; 1.8 Damage to the Blood-Brain-Barrier; 1.9 Programmed Cell Death and Apoptosis; 1.10 Ischemia-induced DNA Damage, DNA Repair, and p53 as Genotoxic Sensor; 1.11 Epigenetics; 1.12 Gene Expression; 1.13 Cell Replacement
1.14 Endogenous Neuroprotection - Ischemic Tolerance1.15 Stroke Induced Immune Depression (SIDS); 1.16 Conclusion; References; 2 Parkinson's Disease; 2.1 Epidemiology of Parkinson's Disease; 2.1.1 Genetic Contribution; 2.1.2 Environmental Factors; 2.2 Oxidative Stress In Parkinson's Disease; 2.3 Role of Alpha-Synuclein in Parkinson's Disease; 2.3.1 Alpha-Synuclein in Lewy Bodies; 2.3.2 Alpha-Synuclein and Oxidative Stress; 2.4 The Involvement of Proteosome in PD; 2.4.1 Parkin Involvement in PD; 2.5 Other Genes Involved in Familial Parkinson's Disease; 2.6 Neurotoxic PD Models
2.6.1 Oxidative Stress2.6.2 Dopamine Homeostasis/Complex I; 2.6.3 Proteasome; 2.7 Genetic Models of Parkinson's Disease; 2.7.1 Alpha-Synuclein Overexpressing Transgenic Animals; 2.7.2 Parkin-related Genetic Models; 2.7.3 Viral Vectors for In Vivo Gene Transfer of Disease-related Proteins to the CNS; 2.7.3.1 Local Overexpression of alpha-synuclein; 2.7.3.2 Local Overexpression of Parkin-related Proteins; Acknowledgements; References; 3 Amyotrophic Lateral Sclerosis; 3.1 Human Motor Neuron Diseases; 3.1.1 Familial ALS Linked to SOD1 Mutations; 3.1.2 Juvenile ALS Linked to Alsin Mutations
3.2 Cell Culture Models of Motoneuron Degeneration3.2.1 Neuronal Cell Lines; 3.2.2 Isolated Motoneuron Cultures; 3.2.3 Organotypic Cultures; 3.3 Animal Models of Motor Neuron Disease; 3.3.1 Axotomy Models; 3.2 Mutant SOD1 Mice; 3.3.3 pmn Mice; 3.4 Future Neuroprotective Approaches; 3.4.1 Axonal Protection; 3.4.2 Mutant SOD1 Knockdown by RNA Interference; 3.5 Conclusion; References; 4 Alzheimer's Disease and Other Neurodegenerative Diseases; Abstract; 4.1 Introduction; 4.2 Transgenic Invertebrates; 4.3 Transgenic Mice; 4.3.1 Tyrosine Hydroxylase (TH) Promoter
4.3.2 Platelet-derived Growth Factor-β (PDGFβ) Promoter4.3.3 Thy1 Promoter; 4.3.4 Prion Protein (PrP) Promoter; 4.3.5 Glial Expression; 4.4 Viral Models; 4.5 Conclusion and Outlook; References; 5 CNS Inflammation; 5.1 Introduction; 5.2 The Pathologic Characteristics of the MS Plaque; 5.3 Axonal Pathology in MS; 5.4 Neuronal Pathology in Multiple Sclerosis; 5.5 Lessons from Animal Models; References; 6 Neurotrauma; 6.1 Introduction; 6.2 In Vivo Models; 6.2.1 Static Brain Injury Models; 6.2.2 Dynamic Brain Injury Models; 6.2.2.1 Indirect Dynamic Brain Injury; 6.2.2.2 Direct Dynamic Brain Injury
6.2.3 Combined Neurotrauma Models
Record Nr. UNINA-9910144731603321
Weinheim, : Wiley-VCH, c2004
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Neuroprotection [[electronic resource] ] : models, mechanisms and therapies / / edited by Mathias Bähr
Neuroprotection [[electronic resource] ] : models, mechanisms and therapies / / edited by Mathias Bähr
Pubbl/distr/stampa Weinheim, : Wiley-VCH, c2004
Descrizione fisica 1 online resource (391 p.)
Disciplina 616.806
Altri autori (Persone) BährMathias
Soggetto topico Nervous system - Diseases - Treatment
Molecular neurobiology
ISBN 1-280-51966-5
9786610519668
3-527-60386-7
3-527-60431-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Neuroprotection Models, Mechanismsand Therapies; Preface; Contents; List of Contributors; I Neurological Disorders - Epidemiology, Clinical Overview, and Model Systems; 1 Stroke; Abstract; 1.1 Introduction; 1.2 The Penumbra Concept; 1.3 Excitotoxicity; 1.4 Oxygen Free Radicals; 1.5 Tissue Acidosis; 1.6 Peri-infarct Depolarizations; 1.7 Inflammation; 1.8 Damage to the Blood-Brain-Barrier; 1.9 Programmed Cell Death and Apoptosis; 1.10 Ischemia-induced DNA Damage, DNA Repair, and p53 as Genotoxic Sensor; 1.11 Epigenetics; 1.12 Gene Expression; 1.13 Cell Replacement
1.14 Endogenous Neuroprotection - Ischemic Tolerance1.15 Stroke Induced Immune Depression (SIDS); 1.16 Conclusion; References; 2 Parkinson's Disease; 2.1 Epidemiology of Parkinson's Disease; 2.1.1 Genetic Contribution; 2.1.2 Environmental Factors; 2.2 Oxidative Stress In Parkinson's Disease; 2.3 Role of Alpha-Synuclein in Parkinson's Disease; 2.3.1 Alpha-Synuclein in Lewy Bodies; 2.3.2 Alpha-Synuclein and Oxidative Stress; 2.4 The Involvement of Proteosome in PD; 2.4.1 Parkin Involvement in PD; 2.5 Other Genes Involved in Familial Parkinson's Disease; 2.6 Neurotoxic PD Models
2.6.1 Oxidative Stress2.6.2 Dopamine Homeostasis/Complex I; 2.6.3 Proteasome; 2.7 Genetic Models of Parkinson's Disease; 2.7.1 Alpha-Synuclein Overexpressing Transgenic Animals; 2.7.2 Parkin-related Genetic Models; 2.7.3 Viral Vectors for In Vivo Gene Transfer of Disease-related Proteins to the CNS; 2.7.3.1 Local Overexpression of alpha-synuclein; 2.7.3.2 Local Overexpression of Parkin-related Proteins; Acknowledgements; References; 3 Amyotrophic Lateral Sclerosis; 3.1 Human Motor Neuron Diseases; 3.1.1 Familial ALS Linked to SOD1 Mutations; 3.1.2 Juvenile ALS Linked to Alsin Mutations
3.2 Cell Culture Models of Motoneuron Degeneration3.2.1 Neuronal Cell Lines; 3.2.2 Isolated Motoneuron Cultures; 3.2.3 Organotypic Cultures; 3.3 Animal Models of Motor Neuron Disease; 3.3.1 Axotomy Models; 3.2 Mutant SOD1 Mice; 3.3.3 pmn Mice; 3.4 Future Neuroprotective Approaches; 3.4.1 Axonal Protection; 3.4.2 Mutant SOD1 Knockdown by RNA Interference; 3.5 Conclusion; References; 4 Alzheimer's Disease and Other Neurodegenerative Diseases; Abstract; 4.1 Introduction; 4.2 Transgenic Invertebrates; 4.3 Transgenic Mice; 4.3.1 Tyrosine Hydroxylase (TH) Promoter
4.3.2 Platelet-derived Growth Factor-β (PDGFβ) Promoter4.3.3 Thy1 Promoter; 4.3.4 Prion Protein (PrP) Promoter; 4.3.5 Glial Expression; 4.4 Viral Models; 4.5 Conclusion and Outlook; References; 5 CNS Inflammation; 5.1 Introduction; 5.2 The Pathologic Characteristics of the MS Plaque; 5.3 Axonal Pathology in MS; 5.4 Neuronal Pathology in Multiple Sclerosis; 5.5 Lessons from Animal Models; References; 6 Neurotrauma; 6.1 Introduction; 6.2 In Vivo Models; 6.2.1 Static Brain Injury Models; 6.2.2 Dynamic Brain Injury Models; 6.2.2.1 Indirect Dynamic Brain Injury; 6.2.2.2 Direct Dynamic Brain Injury
6.2.3 Combined Neurotrauma Models
Record Nr. UNINA-9910830908803321
Weinheim, : Wiley-VCH, c2004
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Neuroprotection [[electronic resource] ] : models, mechanisms and therapies / / edited by Mathias Bähr
Neuroprotection [[electronic resource] ] : models, mechanisms and therapies / / edited by Mathias Bähr
Pubbl/distr/stampa Weinheim, : Wiley-VCH, c2004
Descrizione fisica 1 online resource (391 p.)
Disciplina 616.806
Altri autori (Persone) BährMathias
Soggetto topico Nervous system - Diseases - Treatment
Molecular neurobiology
ISBN 1-280-51966-5
9786610519668
3-527-60386-7
3-527-60431-6
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Neuroprotection Models, Mechanismsand Therapies; Preface; Contents; List of Contributors; I Neurological Disorders - Epidemiology, Clinical Overview, and Model Systems; 1 Stroke; Abstract; 1.1 Introduction; 1.2 The Penumbra Concept; 1.3 Excitotoxicity; 1.4 Oxygen Free Radicals; 1.5 Tissue Acidosis; 1.6 Peri-infarct Depolarizations; 1.7 Inflammation; 1.8 Damage to the Blood-Brain-Barrier; 1.9 Programmed Cell Death and Apoptosis; 1.10 Ischemia-induced DNA Damage, DNA Repair, and p53 as Genotoxic Sensor; 1.11 Epigenetics; 1.12 Gene Expression; 1.13 Cell Replacement
1.14 Endogenous Neuroprotection - Ischemic Tolerance1.15 Stroke Induced Immune Depression (SIDS); 1.16 Conclusion; References; 2 Parkinson's Disease; 2.1 Epidemiology of Parkinson's Disease; 2.1.1 Genetic Contribution; 2.1.2 Environmental Factors; 2.2 Oxidative Stress In Parkinson's Disease; 2.3 Role of Alpha-Synuclein in Parkinson's Disease; 2.3.1 Alpha-Synuclein in Lewy Bodies; 2.3.2 Alpha-Synuclein and Oxidative Stress; 2.4 The Involvement of Proteosome in PD; 2.4.1 Parkin Involvement in PD; 2.5 Other Genes Involved in Familial Parkinson's Disease; 2.6 Neurotoxic PD Models
2.6.1 Oxidative Stress2.6.2 Dopamine Homeostasis/Complex I; 2.6.3 Proteasome; 2.7 Genetic Models of Parkinson's Disease; 2.7.1 Alpha-Synuclein Overexpressing Transgenic Animals; 2.7.2 Parkin-related Genetic Models; 2.7.3 Viral Vectors for In Vivo Gene Transfer of Disease-related Proteins to the CNS; 2.7.3.1 Local Overexpression of alpha-synuclein; 2.7.3.2 Local Overexpression of Parkin-related Proteins; Acknowledgements; References; 3 Amyotrophic Lateral Sclerosis; 3.1 Human Motor Neuron Diseases; 3.1.1 Familial ALS Linked to SOD1 Mutations; 3.1.2 Juvenile ALS Linked to Alsin Mutations
3.2 Cell Culture Models of Motoneuron Degeneration3.2.1 Neuronal Cell Lines; 3.2.2 Isolated Motoneuron Cultures; 3.2.3 Organotypic Cultures; 3.3 Animal Models of Motor Neuron Disease; 3.3.1 Axotomy Models; 3.2 Mutant SOD1 Mice; 3.3.3 pmn Mice; 3.4 Future Neuroprotective Approaches; 3.4.1 Axonal Protection; 3.4.2 Mutant SOD1 Knockdown by RNA Interference; 3.5 Conclusion; References; 4 Alzheimer's Disease and Other Neurodegenerative Diseases; Abstract; 4.1 Introduction; 4.2 Transgenic Invertebrates; 4.3 Transgenic Mice; 4.3.1 Tyrosine Hydroxylase (TH) Promoter
4.3.2 Platelet-derived Growth Factor-β (PDGFβ) Promoter4.3.3 Thy1 Promoter; 4.3.4 Prion Protein (PrP) Promoter; 4.3.5 Glial Expression; 4.4 Viral Models; 4.5 Conclusion and Outlook; References; 5 CNS Inflammation; 5.1 Introduction; 5.2 The Pathologic Characteristics of the MS Plaque; 5.3 Axonal Pathology in MS; 5.4 Neuronal Pathology in Multiple Sclerosis; 5.5 Lessons from Animal Models; References; 6 Neurotrauma; 6.1 Introduction; 6.2 In Vivo Models; 6.2.1 Static Brain Injury Models; 6.2.2 Dynamic Brain Injury Models; 6.2.2.1 Indirect Dynamic Brain Injury; 6.2.2.2 Direct Dynamic Brain Injury
6.2.3 Combined Neurotrauma Models
Record Nr. UNINA-9910841356103321
Weinheim, : Wiley-VCH, c2004
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Occupational Therapy and Neurological Conditions / / Preston Jenny, Edmans Judi著
Occupational Therapy and Neurological Conditions / / Preston Jenny, Edmans Judi著
Pubbl/distr/stampa Wiley-Blackwell, 2016
Descrizione fisica 1 ebook (279 pages) : illustrations
Disciplina 615.8/515
Collana New York Academy of Sciences
Soggetto topico Nervous system - Diseases - Treatment
Occupational therapy
ISBN 1-118-93613-2
1-118-93612-4
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione und
Nota di contenuto Delivering good quality, safe and effective care -- Person-centredness and long term neurological conditions -- Theoretical basis -- Occupation and long term neurological conditions -- Identifying occupational performance enablers and deficits -- Occupational therapy intervention -- Using technology to support participation -- Living with a long term condition -- Planning for the future.
Record Nr. UNINA-9910798394203321
Wiley-Blackwell, 2016
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Occupational therapy and neurological conditions / / edited by Judi Edmans, Jenny Preston on behalf of the College of Occupational Therapists Specialist Section Neurological Practice
Occupational therapy and neurological conditions / / edited by Judi Edmans, Jenny Preston on behalf of the College of Occupational Therapists Specialist Section Neurological Practice
Pubbl/distr/stampa Chichester, West Sussex ; ; Hoboken, NJ : , : John Wiley & Sons, Inc, , 2016
Descrizione fisica 1 ebook (279 pages) : illustrations
Disciplina 615.8/515
Collana New York Academy of Sciences Ser.
Soggetto topico Nervous system - Diseases - Treatment
Occupational therapy
ISBN 1-118-93613-2
1-118-93612-4
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto Delivering good quality, safe and effective care -- Person-centredness and long term neurological conditions -- Theoretical basis -- Occupation and long term neurological conditions -- Identifying occupational performance enablers and deficits -- Occupational therapy intervention -- Using technology to support participation -- Living with a long term condition -- Planning for the future.
Record Nr. UNINA-9910821514603321
Chichester, West Sussex ; ; Hoboken, NJ : , : John Wiley & Sons, Inc, , 2016
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Patterning and cell type specification in the developing CNS and PNS [[electronic resource] /] / editors-in-chief, John L.R. Rubenstein, Pasko Rakic
Patterning and cell type specification in the developing CNS and PNS [[electronic resource] /] / editors-in-chief, John L.R. Rubenstein, Pasko Rakic
Edizione [1st ed.]
Pubbl/distr/stampa Amsterdam ; ; Boston, : Elsevier/AP, 2013
Descrizione fisica 1 online resource (993 p.)
Disciplina 612.8
Altri autori (Persone) RubensteinJohn L. R
RakicPasko
Collana Comprehensive developmental neuroscience
Soggetto topico Developmental neurobiology
Nervous system - Diseases
Neurological errors
Nervous system - Diseases - Treatment
Soggetto genere / forma Electronic books.
ISBN 0-12-397348-1
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Nota di contenuto section 1. Induction and patterning of the CNS and PNS -- section 2. Generation of neuronal diversity -- section 3. Development of glia, blood vessels, choroid plexus, immune cells in the nervous system.
Record Nr. UNINA-9910459132303321
Amsterdam ; ; Boston, : Elsevier/AP, 2013
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui